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Aging human brains are prone to neurodegenerative disorders, the most common being 
the Alzheimer’s disease (AD). Currently, there is no cure for AD, and patients 
progressively lose neurons leading to reduction in the brain mass. Humans cannot 
circumvent and counteract this disease. For instance, chronic inflammation that 
manifests through mild to late stages of the pathology cannot be resolved. The synaptic 
degeneration that underlies cognitive decline cannot be reversed. As a general outcome, 
neurons deteriorate and new neurons cannot replace the lost ones. This is in part due to 
reduced proliferative and neurogenic ability of neural stem cells (NSCs), which normally 
produce neurons, albeit rather a limited lineage. Recently, in AD patients, neurogenic 
outcome was shown to reduce dramatically (Moreno-Jimenez et al., 2019; Tobin et al., 
2019). This lack of neurogenic input from NSCs in human brains is emerging as a new 
aspect through which we might find a chance to counteract AD. One prominent question 
is to find ways to re-activate our NSCs in pathology conditions. 
Zebrafish is known to have a remarkable regenerative ability enabling it to regenerate its 
brain as well. Zebrafish brain possesses several neurogenic regions that harbor NSCs to 
allow continuous neurogenesis throughout adulthood and during regeneration. Radial 
glial cells in the zebrafish brain act as NSCs that respond to neuronal damage by 
enhancing brain plasticity and initiating neuroregeneration. Special molecular 
mechanisms are involved in activating NSCs to form new neurons and initiate the 
regenerative response. In my PhD project, I aimed to identify such regeneration-
associated molecular mechanisms in AD-like neurodegenerative conditions. 
To investigate the molecular programs that mediate regenerative response in 
neurodegenerative conditions, we first generated an amyloid-mediated 
neurodegeneration model in adult zebrafish to mimic certain pathophysiological aspects 
of AD. We used synthetic Amyloid-β-42 (Aβ42) peptides and injected into the zebrafish 
brain using cerebroventricular microinjection (CVMI) method. These peptides were 
tagged with robust cell-penetrating peptide, which were previously shown to efficiently 
deliver cargo molecules into the zebrafish brain. This approach led to an acute model of 
neurodegeneration in which Aβ42 deposition was prominent in neurons in adult 
zebrafish brain, and also exhibited phenotypes reminiscent of human AD 
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pathophysiology: apoptosis, inflammation, synaptic degeneration, and cognitive deficits. 
In contrast to the mammals, zebrafish brain induced the NSC proliferation and enhanced 
the neurogenesis to initiate a regenerative response. To identify the mechanisms behind 
this response, we performed whole-RNA transcriptome analyses, which revealed that 
several genes associated with immune-related signaling pathways were significantly 
enriched. We further found that Interleukin-4 (IL-4) is activated primarily in neurons and 
microglia in response to Aβ42, and is sufficient to increase NSC proliferation and 
neurogenesis. IL-4 binds to its cognate receptor IL4R that is expressed in NSCs, and 
activates the downstream signaling cascade via STAT6 phosphorylation. These results 
indicate that Aβ42-induced neurodegeneration in adult zebrafish brain leads to 
regenerative response mediated by direct activation of NSCs through a neuro-immune 
cross talk mediated by IL-4 signaling via STAT6 phosphorylation. 
In an approach to further elucidate how IL-4 signaling would mediate the NSCs 
response, we performed another whole-RNA transcriptome analyses after IL-4 treatment 
in homeostatic brains. We found that, apart from direct activation of NSC proliferation, 
IL-4 also has an indirect effect on NSCs through factors secreted by neurons. Single-cell 
transcriptomics further revealed the heterogeneity of the NSCs pool in the zebrafish 
brain, which responds directly or indirectly to Aβ42-induced IL-4. We found that IL-4 
induces NSC proliferation and subsequent neurogenesis by suppressing the tryptophan 
metabolism and reducing the production of the neurotransmitter Serotonin. NSC 
proliferation was suppressed by Serotonin via downregulation of brain-derived 
neurotrophic factor (BDNF) in Serotonin-responsive periventricular neurons. BDNF itself 
enhanced NSC plasticity and neurogenesis via NGFRA/NFkB signaling in zebrafish. 
This regulatory network is not active in rodents. With these results, we identified a novel 
IL-4-dependent molecular mechanism of NSC proliferation that is mediated by 
Serotonin-BDNF-NGFRA regulatory axis. Our results elucidated a novel crosstalk 
through neuron-glia interaction that regulates regenerative neurogenesis in adult 
zebrafish AD model. Additionally, we identified two functionally distinct populations of 
NSCs, which mediate NSCs plasticity through distinct gene expression profiles and 
versatile signaling mechanisms. 
Collectively, we propose that zebrafish serves as an excellent model to investigate 
regeneration-associated mechanisms that enables the inherent capacity of enhanced 
regenerative neurogenesis upon neurodegeneration. We found that specific signaling 
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mechanisms are active in specific subtypes of NSC populations in adult zebrafish brain. 
Since these mechanisms are normally inactive in NSCs of mammalian brains, 
particularly in rodents after AD-like conditions, we speculate that activating such 
candidate mechanisms in distinct NSCs population in mammalian brains could induce 
NSCs plasticity response. Indeed, our studies also suggested that some of these 
candidates could be harnessed to force human NSCs to become proliferative and 
neurogenic. Therefore, my PhD work opened up a new avenue of research that utilizes 
zebrafish for understanding what it takes for a vertebrate NSC to remain neurogenic 
even after AD pathology. Overall, I believe that this research route will be instrumental in 






Das alternde menschliche Gehirn neigt zu neurodegenerativen Störungen, wobei die 
Alzheimer-Krankheit (AD) die häufigste ist. Gegenwärtig gibt es keine Heilung für die 
Alzheimer-Krankheit, und die Patienten verlieren nach und nach Nervenzellen, was zu 
einer Verringerung der Hirnmasse führt. Der Mensch kann diese Krankheit nicht 
umgehen und ihr entgegenwirken. Beispielsweise können chronische Entzündungen, die 
sich in leichten bis späten Stadien der Pathologie manifestieren, nicht behoben werden. 
Die synaptische Degeneration, die dem kognitiven Abbau zugrunde liegt, kann nicht 
rückgängig gemacht werden. Als allgemeine Folge davon sterben Neuronen und neue 
Neuronen können die verlorenen nicht ersetzen. Dies ist zum Teil auf die verminderte 
proliferative und neurogene Fähigkeit der neuralen Stammzellen (NSZ) zurückzuführen, 
die normalerweise Neuronen produzieren, wenn auch in einer eher begrenzten Zahl. 
Kürzlich wurde bei Alzheimer-Patienten eine drastische Verschlechterung der 
neurologischen Ergebnisse gezeigt (Moreno-Jimenez et al., 2019; Tobin et al., 2019). 
Dieser Mangel an neurogenem Input von NSZs im menschlichen Gehirn erweist sich als 
ein neuer Aspekt, welcher eine Chance sein könnte, der Alzheimer-Erkrankung 
entgegenzuwirken. Eine wichtige Frage ist, wie wir unsere NSV unter pathologischen 
Bedingungen reaktivieren können. 
Es ist bekannt, dass der Zebrafisch eine bemerkenswerte Regenerationsfähigkeit 
besitzt, die es ihm ermöglicht, auch sein Gehirn zu regenerieren. Das Gehirn des 
Zebrafischs besitzt mehrere neurogene Regionen, die NSZ beherbergen, um eine 
kontinuierliche Neurogenese während des gesamten Erwachsenenalters und während 
der Regeneration zu ermöglichen. Radiale Gliazellen im Zebrafischhirn fungieren als 
NSZ, die auf neuronale Schäden reagieren, indem sie die Plastizität des Gehirns 
verbessern und die Neuroregeneration einleiten. Spezielle molekulare Mechanismen 
sind an der Aktivierung von NSZ beteiligt, um neue Nervenzellen zu bilden und die 
Regeneration einzuleiten. In meinem Promotionsprojekt versuchte ich, solche 
regenerationsassoziierten molekularen Mechanismen bei AD-ähnlichen 
neurodegenerativen Erkrankungen zu identifizieren. 
Um die molekularen Programme zu untersuchen, die die regenerative Reaktion bei 
neurodegenerativen Erkrankungen vermitteln, haben wir zunächst ein Amyloid-
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vermitteltes Neurodegeneration-Modell bei erwachsenen Zebrafischen entwickelt, um 
bestimmte pathophysiologische Aspekte der Alzheimer-Erkrankung nachzuahmen. Wir 
verwendeten synthetische Amyloid-β-42 (Aβ42) Peptide und injizierten sie mit der 
Methode der zerebroventrikulären Mikroinjektion (CVMI) in das Gehirn des Zebrafisches. 
Diese Peptide wurden mit einem robusten zelldurchdringenden Peptid markiert, von dem 
zuvor gezeigt wurde, dass es effizient Moleküle in das Zebrafischhirn transportiert . 
Dieser Ansatz führte zu einem akuten Modell der Neurodegeneration, bei dem Aβ42 
Ablagerungen in Neuronen im Gehirn erwachsener Zebrafische zahlreich vorhanden 
waren und auch Phänotypen zeigten, die an die Pathophysiologie der menschlichen 
Alzheimer-Erkrankung erinnerten: Apoptose, Entzündung, synaptische Degeneration 
und kognitive Defizite. Im Gegensatz zu den Säugetieren induzierte das Zebrafischhirn 
die NSZ-Proliferation und verstärkte die Neurogenese, um eine regenerative Reaktion 
einzuleiten. Um die Mechanismen hinter dieser Reaktion zu identifizieren, führten wir 
Analysen des gesamten RNA-Transkriptoms durch, die zeigten, dass mehrere Gene, die 
mit immunbezogenen Signalwegen assoziiert sind, signifikant angereichert waren. Wir 
fanden ferner heraus, dass Interleukin-4 (IL-4) als Reaktion auf Aβ42 vor allem in 
Neuronen und Mikroglia aktiviert wird und ausreicht, um die NSZ-Proliferation und die 
Neurogenese zu steigern. IL-4 bindet an seinen kognitiven Rezeptor IL4R, der in NSZs 
exprimiert wird, und aktiviert die nachgeschaltete Signalkaskade über die STAT6-
Phosphorylierung. Diese Ergebnisse deuten darauf hin, dass die Aβ42-induzierte 
Neurodegeneration im Gehirn von erwachsenen Zebrafischen zu einer regenerativen 
Reaktion führt, die durch direkte Aktivierung von NSZs durch einen neuro-immunen 
Cross-Talk vermittelt wird, der durch IL-4-Signale über die STAT6-Phosphorylierung 
vermittelt wird. 
Um weiter zu klären, wie die IL-4-Signalisierung die Reaktion der NSZs vermittelt, 
führten wir nach der IL-4-Behandlung in homöostatischen Gehirnen eine weitere 
Analyse des gesamten RNA-Transkriptoms durch. Wir fanden heraus, dass IL-4 neben 
der direkten Aktivierung der NSZ-Proliferation auch eine indirekte Wirkung auf die NSZs 
durch Faktoren hat, die von Neuronen sezerniert werden. Die Einzelzell-Transkriptom-
Analyse zeigte zudem die Heterogenität des NSZ-Pools im Zebrafischhirn, der direkt 
oder indirekt auf das durch Aβ42 induzierte IL-4 reagiert. Wir fanden heraus, dass IL-4 
die NSZ-Proliferation und die nachfolgende Neurogenese durch die Unterdrückung des 
Tryptophan-Stoffwechsels und die Verringerung der Produktion des Neurotransmitters 
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Serotonin induziert. Die NSZ-Proliferation wurde durch Serotonin über die 
Herunterregulierung des hirnabgeleiteten neurotrophen Faktors (BDNF) in Serotonin-
responsiven periventrikulären Neuronen unterdrückt. BDNF selbst erhöhte die NSZ-
Plastizität und Neurogenese über die NGFRA/NFkB-Signalisierung im Zebrafisch. 
Dieses regulatorische Netzwerk ist in Mäusen nicht aktiv. Mit diesen Ergebnissen 
identifizierten wir einen neuen IL-4-abhängigen molekularen Mechanismus der NSZ-
Proliferation, der durch die Serotonin-BDNF-NGFRA-Regulationsachse vermittelt wird. 
Unsere Ergebnisse haben eine neurartige gegenseitige Beziehung durch Neuron-Glia-
Interaktion aufgeklärt, welche die regenerative Neurogenese im AD-Modell des adulten 
Zebrafisches reguliert. Darüber hinaus identifizierten wir zwei funktionell 
unterschiedliche NSZ-Populationen, die die Plastizität der NSZ durch unterschiedliche 
Genexpressionsprofile und vielseitige Signalmechanismen vermitteln. 
Gemeinsam haben wir festegestellt, dass der Zebrafisch als ein ausgezeichnetes Modell 
zur Untersuchung regenerationsassoziierter Mechanismen dient, die die inhärente 
Fähigkeit einer verstärkten regenerativen Neurogenese bei Neurodegeneration 
ermöglichen. Wir fanden heraus, dass spezifische Signalmechanismen in bestimmten 
Subtypen von NSZ-Populationen im Gehirn erwachsener Zebrafische aktiv sind. Da 
diese Mechanismen in NSZs von Säugetiergehirnen normalerweise inaktiv sind, 
insbesondere bei Mäusen nach AD-ähnlichen Zuständen, spekulieren wir, dass die 
Aktivierung solcher Kandidatenmechanismen in bestimmten NSZ-Populationen in 
Säugetiergehirnen die Plastizitätsreaktion von NSZ induzieren könnte. Tatsächlich legen 
unsere Studien auch nahe, dass einige dieser Kandidaten genutzt werden könnten, um 
menschliche NSZs anzuregen, proliferativ und neurogen zu werden. Daher eröffnete 
meine Doktorarbeit einen neuen Forschungsweg, bei dem Zebrafische zum Verständnis 
dessen eingesetzt werden, was nötig ist, damit die NSZs eines Wirbeltiers auch nach 
einer Alzheimer-Pathologie neurogen bleiben. Insgesamt glaube ich, dass dieser 
Forschungsweg entscheidend dazu beitragen wird, von der Natur inspirierte 
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Neurodegenerative diseases affect millions of people worldwide. These are specific 
group of disorders that are associated with the disruption of structure and the function of 
the central nervous system (CNS) or the peripheral nervous system (PNS). Patients with 
neurodegenerative diseases show signs that impinge on their memory, movement, 
speech, intelligence and lead to debilitating outcomes (Voisin & Vellas, 2009). The most 
common neurodegenerative disease is Alzheimer’s disease (AD) (Evans et al., 1989; 
Bondi et al., 2017). Although, several efforts have been made to understand how and 
why AD occurs, it still remains highly complex and elusive. 
 
1.1 Alzheimer’s disease 
Alzheimer’s disease (AD) is a worldwide health challenge. It is characterized by the 
chronic loss of neurons and synapses in the cerebral cortex and certain subcortical 
regions, along with a significant reduction in the brain mass (West et al., 1994; Wenk, 
2003; Blennow et al., 2006). AD is also known to be the most common form of dementia, 
as World Alzheimer Report 2019 published by Alzheimer’s Disease International 
estimated about 50 million people are living with dementia globally. This figure is 
expected to increase progressively over the course of the next few decades and reach 
about 152 million by 2050 (Alzheimer’s Disease International, 2019). There is no 
effective treatment or cure to this disease to date. Thus, it is of utmost importance to 
understand the manifestation and progression of AD, and to develop effective prevention 
strategies. There have been continuous efforts in last few decades towards the 
development of different therapeutic approaches to prevent or slow down the 
progression of the disease (Ballard et al., 2011; Cummings et al., 2017; Piton et al., 
2018). However, several failed clinical trials for the treatment of AD suggest that the 
existing AD drug researches have not been successful to find an effective cure for this 
disease. Hence, it could also be equally important to look into novel and unconventional 
therapeutic interventions to revert the diseased condition. 
 
AD is a multifactorial disease. Certain risk factors such as aging and specific genetic 
polymorphisms are causative to the disease. Personal lifestyle factors clustered around 
diet, education, and physical activity and compromised resilience factors also influences 
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the disease occurrence (Kempermann, 2019). In addition, inflammation, diabetes, 
cardiovascular diseases, traumatic brain injury, stroke, midlife hypertension, stress, 
midlife obesity, gender, endocrine conditions, oxidative stress, inflammation, vitamin 
deficiencies, immune and metabolic conditions, and chemical exposure are also likely to 
contribute to the development of AD (Barnes & Yaffe, 2011). Thus, all these 
multifactorial aspects should be considered for the effective development of AD 
therapeutics along with healthy aging practices. 
 
1.2 Features of AD 
AD was first described in 1906 by German neuropathologist Alois Alzheimer observing 
the brain of a female patient suffering from dementia (Alzheimer, 1907; Stelzmann et al., 
1995). He observed a significant shrinkage of the brain mass and accumulation of some 
abnormal aggregates in the tissue specimens from a brain autopsy (Figure 1). Similar 
diagnoses were further reported in the following years and in 1910, another German 
psychiatrist Emil Kraepelin coined the term “Alzheimer’s Disease” in his book while 
reporting similar cases (Kraepelin, 1910). 
 
Figure 1: History of Alzheimer’s disease. Alois Alzheimer (left) and his illustrations of plaques and 
astrogliosis observed in a histological section of the brain from his patient (right). Modified from 
(Chun & Lee, 2018). 
 
It was only in the 1980s, the two major proteins involved in AD – the Amyloid Precursor 
Protein (APP) and the Tau protein were discovered. APP is a transmembrane protein 
that has functions associated with neuronal development, neurite growth and axonal 
transport (Kang et al., 1987); and Tau is a microtubule-associated protein that stabilizes 
cytoskeletal assembly in terms of microtubule (Grundke-Iqbal et al., 1986). 
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Abnormal processing and misfolding of these proteins are thought to be the major 
underlying cause of AD. Hence, the classical neuropathological hallmarks associated 
with AD were illustrated by the presence of intracellular and extracellular misfolded 
protein aggregates in the form of senile plaques and the neurofibrillary tangles (NFTs) 
(Lewis et al., 2000; Hardy & Selkoe, 2002). Senile plaques, also known as amyloid 
plaques, are composed of amyloid-β (Aβ) peptide deposits that are generated after 
abnormal processing of APP due to sequential proteolytic cleavage by β-secretase and 
γ-secretase (Glenner & Wong, 1984; Haass, 2004). NFTs are misfolded protein 
aggregates of hyperphosphorylated tau protein (Grundke-Iqbal et al., 1986). Considering 
these two features associated with AD, two major hypotheses – the Amyloid hypothesis 
and the Tau hypothesis have been widely followed over the past few decades. Recently, 
more descriptive hypotheses analyzing various aspects of AD have been proposed, 
including the cholinergic hypothesis, mitochondrial cascade hypothesis, calcium 
homeostasis hypothesis, neurovascular hypothesis, inflammatory hypothesis, metal ion 
hypothesis, and lymphatic system hypothesis (extensively reviewed in (Liu et al., 2019)). 
 
Despite the substantial knowledge about the major pathological features of AD, the 
underlying mechanism behind the disease progression still remains poorly understood. 
Clinically, AD is classified mainly into two forms: familial AD (FAD) and sporadic AD 
(SAD) (Hornsten et al., 2007). The incidence of FAD, an early-onset form of AD, 
accounts for less than 5% of all AD cases (Ertekin-Taner, 2007) and is linked mainly to 
three genes: APP, presenilin 1 (PSEN1) and presenilin 2 (PSEN2). Mutations in these 
genes are associated with an increase in the production of Aβ42 peptide and susceptible 
to aggregation (Scheuner et al., 1996). In case of SAD, a more prevalent form that 
accounts for more than 95% of all AD cases, the prominent risk factor has consistently 
been the interaction between the genetic susceptibility factors and environment leading 
to the expression of the ε4 allele of the apolipoprotein E gene (APOE) (Corder et al., 
1993). Recently, genome-wide association studies (GWAS) further identified 29 more 
risk genetic loci that could contribute to polygenic forms of AD (Bertram & Tanzi, 2019; 
Jansen et al., 2019; Kunkle et al., 2019). These genes are extensively studied to 
understand the mechanisms behind AD pathogenesis; however the ultimate etiology of 
AD remains obscure. Thus, the association of AD with all these genes, from APP and γ-
secretase components to APOE and genes from GWAS, serve as a basis for generating 
animal models of the disease to further gain a better understanding of the disease. 
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1.3 Animal models of AD 
Human diseases can be studied extensively using model organisms that are able to 
recapitulate at least some of the pathophysiological conditions. Although animal models 
cannot fully mimic entire human disease state, they are useful tools to investigate 
reductionist questions. Such disease models enable us to have an in-depth 
understanding of disease progression as well as the genetic basis of the disease. In 
addition, they also serve as a platform to investigate the potential therapeutic targets that 
can impede the disease progression. Several animal models have been generated to 
study AD, ranging from simpler invertebrate animals such as Caenorhabditis elegans 
and Drosophila melanogaster to complex vertebrate models such as rodents and non-
human primates (Saraceno et al., 2013; Drummond & Wisniewski, 2017). Rodents are 
the major animal models in AD research, but significant additional insight has been 
provided from other species, for instance invertebrates, as well. Due to the ease in 
genetic manipulation and the presence of orthologues of AD genes, multiple transgenic 
lines expressing human APP, Aβ and Tau have been developed in invertebrate animal 
models to study AD (Wu & Luo, 2005; Mhatre et al., 2013; Fernandez-Funez et al., 
2015). These models have been handful in high-throughput genetic or drug screens for 
drug discovery research (Ségalat, 2007; Teo et al., 2020). However, their use in AD is 
limited due to greater differences with humans in terms of genetic homology, and the 
complexity of structural and behavioral aspects of the nervous system. 
 
The vast majority of experimental animal models in AD research are transgenic mice 
that overexpress human genes associated with AD and resulting in the formation of 
amyloid plaques. The first transgenic AD mouse model, PD-APP (APP with Val-717-Phe 
mutation) was developed in 1995 overexpressing mutant form of human APP that 
showed features similar to human AD pathology: prominent amyloid plaques, gliosis, 
synaptic degeneration and even cognitive decline (Games et al., 1995). Since then, 
more transgenic mice models were developed overexpressing different variants of 
mutant genes associated with the AD (for example: APP, presenilin 1 - PSEN1, 
presenilin 2 - PSEN2, Tau, apolipoprotein E - APOE) alone or in combination, each 
leading to different and more robust phenotype of AD-associated pathology (Wisniewski 
& Sigurdsson, 2010; Hall & Roberson, 2012; Puzzo et al., 2015). Knock-in mice models 
have also been developed by knocking-in a human gene with specific mutations into the 
mice that shows humanized mouse Aβ (Li et al., 2014; Saito et al., 2014). Despite 
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representing mammalian physiology and the variety of models expressing disease-
related proteins, none of these rodent models show neuronal death as observed in 
human AD. 
 
In addition, non-human primates (such as chimpanzees, gorillas, rhesus monkeys etc.) 
also offers unique advantage to study AD due to their close biological proximity to 
humans and a natural accumulation of Aβ, but only limited studies have been carried out 
because of their long lifespan and ethical concerns (Heuer et al., 2012; Braidy et al., 
2015; Drummond & Wisniewski, 2017). All in all, these experimental models of AD 
offered much promise and hope about the understanding of AD pathogenesis to 
decipher questions which were previously impossible to examine in humans. 
 
Although various aspects of neuro-pathophysiology of AD were modeled in various 
animal models, it is exceptionally crucial to acknowledge that none of the available 
models fully recapitulated the whole spectrum of the human pathology (LaFerla & Green, 
2012). Most of the existing AD models only display specific pathological features, mainly 
amyloid accumulation and relevant phenotypes, which highlight the fact that they fail to 
represent other downstream molecular and cellular disease phenotypes. This could be 
the reason for the high failure rate of AD therapeutics in clinical settings albeit their 
success in preclinical testing using these animal models (Mehta et al., 2017; Mullane & 
Williams, 2019). Hence, AD remains to be a genetically and environmentally complex 
disease, and requires further investigation to understand the cellular basis of AD 
pathogenesis to bolster any advancement of therapeutic deliberations. 
 
1.4 Cellular aspects of AD 
Descriptive AD research suggests that the cellular phase of AD progression is complex, 
and evolves over decades from early benign reactions to a chronic irreversible state. 
Many studies have demonstrated that AD affects neurons in the brain, as plaques and 
tangles formation impact the neurites leading to synaptic deficits and neuronal loss 
(DeKosky & Scheff, 1990; Terry et al., 1991; Terry, 2000). However, equally abundant 
are the other non-neuronal brain cell types in the brain, such as astrocytes, microglia 
and neural stem cells (NSCs), and those cells are also affected by the dyshomeostasis 
of the brain. Researchers have found that every cell type, both neuronal and non-
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neuronal cells, present in the brain showed differences in gene expression in AD 
patients compared to healthy controls, and these differences delineate a certain 
pathological state. Such cell-type-specific changes in gene expression mainly occurred 
in the early phase of disease progression (Mathys et al., 2019). Although the initial 
cause of AD is unclear, recent reports imply a multi-dimensional causality for AD, which 
concerns processes like chronic inflammation, excitotoxicity, altered neuronal circuit 
dynamics, impaired myelin function and reduced NSC plasticity and neurogenesis 
(Hardy & Selkoe, 2002; De Strooper & Karran, 2016; Scheltens et al., 2016). 
 
 
Figure 2: Pathological feature of Alzheimer’s disease. Comparative illustration of pathological 
features observed in healthy (left) and AD (right) condition. Modified from (Congdon & 
Sigurdsson, 2018). 
 
Recent studies in experimental animal models as well as AD patients have pointed out 
that AD pathophysiology may not only be the outcome of neuronal dystrophy, but non-
neuronal cells could also contribute to the progression of the disease (Figure 2) (De 
Strooper & Karran, 2016; S. H. Choi & Tanzi, 2019). The most abundant glial cells in the 
brain are astrocytes, which have an important role in synapse formation and are 
responsible for brain homeostasis. In pathological conditions, reactive astrocytes are 
observed as an early event in a dynamic response to brain damage. In fact, astrogliosis 
was reported as a prominent feature of AD by Alois Alzheimer himself. In addition, there 
are reports that show increased Aβ levels corresponding to astrocyte activation during 
AD pathogenesis suggesting a close relationship between amyloidosis and astrogliosis 
(Carter et al., 2012; Lian & Zheng, 2016). Experiments in AD mice models show 
astrogliosis as an early event even before the appearance of amyloid deposits (Heneka 
et al., 2005), and are known to mediate plaque pathogenesis (Kraft et al., 2013). 
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Astrocytes are also known to modulate the status of microglial activation (Lian et al., 
2016). Since microglias are phagocytic cells of the CNS, they respond to toxic 
aggregations of proteins, maintain the health of the brain, and sustain an active 
inflammatory response if needed. Aberrant function of microglia fails to clear up the 
protein debris, for example in case of AD mice model APP/PS1 (Jankowsky et al., 2004), 
failure of amyloid clearance, in turn, facilitates protein aggregation and formation of the 
plaques (Streit, 2004; Hickman et al., 2008; Griciuc et al., 2013). Furthermore, studies 
have shown a strong correlation between the mutations in inflammatory genes and AD 
(Lambert et al., 2013; Karch & Goate, 2015; Zhang et al., 2015). For example: a 
mutation to TREM2 (triggering receptor expressed on myeloid cells 2) gene significantly 
increased the risk of AD by 3- to 5-fold (Guerreiro et al., 2013; Jonsson et al., 2013). In 
recent years, more elaborate studies have further demonstrated the involvement of 
microglia in AD pathogenesis (Heneka et al., 2015; Keren-Shaul et al., 2017; Sala-
Frigerio et al., 2019). Another component of the brain that is affected by AD is the 
vascular system, and vascular pathology such as cerebral amyloid angiopathy is caused 
by widespread deposition of Aβ in the vasculature. The vascular hypothesis suggests 
that vascular pathology considerably increases the risk of AD (Zlokovic, 2011). Similarly, 
studies in different AD mice models show amplified demyelination phenotype and the 
role of Aβ to trigger impaired oligodendrocytes function (Desai et al., 2010; Behrendt et 
al., 2013). Prominent myelin breakdown in AD patients as assessed by MRI further 
provides a link between oligodendrocytes and AD (Bartzokis, 2011). These reports thus 
emphasize the possible role of oligodendrocytes in the cellular phase of AD. 
 
Taken together, alterations in functions of neurons, astrocytes, microglia, 
oligodendrocytes as well as the vascular systems, all contribute to the progression of the 
disease. Therefore, understanding the contribution of every subtype or physiological 
state of every cell is of utmost importance in order to address the possibilities of AD 
therapy. 
 
1.5 Neural stem cells, Neurogenesis and AD 
Neural stem cells (NSCs) are self-renewing, multipotent cells that are capable of forming 
all cells from the CNS (Reynolds & Weiss, 1992). The proficiency of NSCs however 
varies distinctly during development and adulthood in the mammalian CNS. During 
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development, NSCs give rise to all different neural cell lineages to generate neurons, 
astrocytes, and oligodendrocytes and provides the basis for the development of entire 
nervous system (Gotz & Huttner, 2005). Besides, neurogenesis comprises of different 
stages, including self-renewal and proliferation of NSCs within the niche, followed by the 
differentiation and migration of newly formed neurons to appropriate regions of the brain 
and integration into the neuronal circuits (Gage, 2000, 2002; van Praag et al., 2002). 
But, during adulthood, NSCs are restrictive and limited to very few stem cell niches 
within the neurogenic areas, namely the sub-ventricular zone (SVZ) of the lateral 
ventricles and the sub-granular zone (SGZ) of the dentate gyrus in the hippocampus 
(Altman & Das, 1965; Doetsch et al., 1999; Kempermann, 2011). These neurogenic 
regions act as a reservoir for NSCs and thus provide adult brain a capability to 
continuously generate neurons throughout life. This process of generating neurons from 
NSCs in adult brain is called adult neurogenesis, which is insufficient to counteract the 
neurodegenerative conditions like in AD. 
 
One reason why human brains cannot recover from neuronal loss during AD might be 
the reduced neurogenic outcome from NSCs during the disease progression (Hollands 
et al., 2016; Tincer et al., 2016). Recent findings show that impaired neurogenesis is 
sufficient to impede the learning and memory process, contributing to cognitive 
dysfunction as observed in AD (Shors et al., 2001; Imayoshi et al., 2008). Furthermore, 
reduced NSC activity and neurogenesis had already been reported in the studies with 
AD models of mouse (Haughey et al., 2002) as well as in the brains of AD patients 
(Moreno-Jimenez et al., 2019; Tobin et al., 2019). Together with neuronal death and 
synaptic dysfunction, reduced production of new neurons from NSCs in the AD brain 
may further contribute to pathogenesis of the disease (Kizil & Bhattarai, 2018; S. H. Choi 
& Tanzi, 2019). On the other hand, AD risk genes such as APP, PSEN1 and APOE are 
also known to contribute in modulating NSCs activity and neurogenesis (Gadadhar et al., 
2011; Yang et al., 2011), implying a close association of NSCs with AD pathogenesis. 
Hence, it is crucial to understand the mechanism behind compromised NSC plasticity 
and impaired neurogenesis to explore the potential of NSCs as an alternative 




1.6 Zebrafish - a model organism for Regeneration 
Over the decades, Zebrafish (Danio rerio) emerged as an important animal model to 
study vertebrate developmental biology. It possesses multiple experimental advantages 
such as high physiological and genomic homology to mammals, external fertilization, 
transparent embryos and larvae, amenable to genetic manipulations, large clutches and 
reasonably short reproductive cycle (Postlethwait et al., 2000; Nusslein-Volhard & 
Dahm, 2002; Veldman & Lin, 2008). More recently, this model has been extensively 
popular to understand additional aspects of vertebrate biology varying from disease 
mechanism and modeling, stem cells and tissue regeneration to drug discovery and 
translational biomedical research. The main motivation that drives our research is its 
remarkable regenerative ability. 
 
Zebrafish have a tremendous ability to regenerate its damaged or lost tissues. It can 
efficiently regenerate a wide variety of tissues and organs such as fins, heart, liver, 
kidney and CNS (Raymond et al., 2006; Nakatani et al., 2007; Poss, 2007; Kaslin et al., 
2008; Reimer et al., 2008; Brignull et al., 2009; Zupanc, 2009; Antos & Brand, 2010; 
Curado et al., 2010; LeClair & Topczewski, 2010; Diep et al., 2011; Fleisch et al., 2011; 
W. Y. Choi & Poss, 2012; Kizil et al., 2012a). Especially in CNS, zebrafish exhibits 
regenerative potential in the brain, retina, optic nerve and the spinal cord (Becker & 
Becker, 2008; Kizil et al., 2012a). There has been extensive research over the last few 
years on the regenerative potential of zebrafish using several injury paradigms, such as 
mechanical lesions, genetic ablation or use of cytotoxic drugs treatment (Kikuchi et al., 
2010; Kroehne et al., 2011; Marz et al., 2011; Baumgart et al., 2012; Kishimoto et al., 
2012; Shao et al., 2013). The adult zebrafish brain has been shown to replenish lost 
neurons effectively with complete restoration of morphology and function following a stab 
injury paradigm (Kroehne et al., 2011; Marz et al., 2011; Baumgart et al., 2012; 
Kishimoto et al., 2012; Barbosa et al., 2015). These early evidence thus supports the 
aspects of regenerative biology as zebrafish can successfully cope with neuronal insult. 
Therefore, understanding the mechanisms that zebrafish employs for regeneration and 
repair could open-up new avenues towards regenerative therapies in humans. 
Zebrafish has also been used as a disease model to study human neurological 
disorders, including AD as well as Tauopathy (Paquet et al., 2009; Xi et al., 2011; 
Newman et al., 2014; Saleem & Kannan, 2018). There is a profound resemblance of 
neuroanatomic and neurochemical pathways of the zebrafish brain with the human 
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brain, including those that play roles in human disease (Santana et al., 2012). In fact, 
zebrafish genes share 70-80% homology with that of the human genes, and zebrafish 
genes orthologous to those implicated with AD are defined (Howe et al., 2013; Newman 
et al., 2014). Accordingly, several transgenic zebrafish lines have been generated to 
model AD, but none of them exhibit neuropathological phenotype (Newman et al., 2010; 
van Bebber et al., 2013; Ebrahimie et al., 2016; Cosacak et al., 2017; Lopez et al., 
2017). However, the recent advancement in genome editing techniques surely provides 
an exciting opportunity to develop zebrafish genetic models of AD that could aid a better 
understanding of the disease. Additionally, it is also important to look for alternative 
strategies to attain neurodegeneration in zebrafish that could facilitate investigation of its 
regenerative ability. 
 
1.7 Regeneration in adult zebrafish brain 
Zebrafish possess an immense ability for brain regeneration. Unlike mammals, it can 
effectively regenerate its brain after neuronal insult, and thus serves as an excellent 
model to gain knowledge about brain repair and regeneration (Chapouton et al., 2007; 
Kaslin et al., 2008; Baumgart et al., 2012; Kishimoto et al., 2012). The successful brain 
regeneration ability in zebrafish is driven by the concept of NSC plasticity and 
neurogenesis, which allows the generation of new neurons to replace the lost ones 
following any neuronal insult in the form of injury or diseased condition. The presence of 
widespread stem cell niches and neurogenic regions, that harbor proliferative NSCs, in 
the zebrafish brain allows replenishment of lost cells (Figure 3) (Grandel et al., 2006; 
Kaslin et al., 2008; Kizil et al., 2012a). Moreover, this feature of neurogenesis in 
zebrafish also relies on the activation of stem/progenitor cells that are governed by 
specific molecular mechanisms (Cosacak et al., 2015). Only very few of such molecular 
mechanisms that regulate NSC plasticity and regenerative response have been 
identified, such as cysteinyl leukotriene signaling pathway (Kyritsis et al., 2012), the zinc 
finger transcription factor Gata3 (Kizil et al., 2012c), chemokine receptor cxcr5 (Kizil et 
al., 2012b), notch signaling (Alunni et al., 2013), notch-signaling-regulated basic helix-
loop-helix protein id1 (Rodriguez-Viales et al., 2015). These targets were identified using 
various injury models in adult zebrafish. These factors can regulate endogenous neural 
stem cell activity in a distinct manner suggesting that the observed regenerative 




Figure 3: Neurogenic regions of the zebrafish brain. Sagittal schematic overview of adult stem 
cell niches and neurogenic areas in the adult zebrafish brain. Modified from (Kizil et al., 2012a). 
 
A successful regenerative response comprises of series of events including activation of 
NSCs, proliferation, differentiation, migration, survival, and integration of newly formed 
cells. Moreover, regenerative neurogenesis could also depend upon genes and 
pathways contributing essentially to developmental programs of specification, patterning 
and morphogenesis (Cosacak et al., 2015; Alunni & Bally-Cuif, 2016). These events are 
tightly regulated by a mechanism that may constitute the expression of one or more 
intermediate genes and/or their interaction signaling cascade. Zebrafish thus serves as 
an excellent model not only to study such molecular mechanisms essential for activation 
of endogenous stem cell populations for regeneration, but also to further provide insights 
on prolonged survival of new cells as well as better integration of newly formed cells into 
the existing tissue for functional recovery (Cosacak et al., 2015; Kizil, 2018; Kizil & 
Bhattarai, 2018). Furthermore, given the availability of genetic manipulation tool and 
targeted gene expression method along with advancement in single-cell technology, 
zebrafish can also facilitate understanding of the heterogeneity of NSCs and the role of 
each individual cell population involved in regeneration (Cosacak et al., 2019; Cosacak 
et al., 2020). Hence, the remarkable feature of regeneration in zebrafish has driven our 
research to dissect how zebrafish can efficiently regenerate its brain in response to 
damage, which a mammalian brain fails to do. 
 
1.8 Regeneration in mammalian brain 
The mammalian brain also harbors NSCs in its stem cell niches that give rise to newborn 
neurons during development as well as during adulthood (Doetsch et al., 1999; Gage, 
2000; Conti & Cattaneo, 2010; Gage & Temple, 2013). Though constitutive 
neurogenesis persists in these neurogenic regions, upon injury they fail to attain efficient 
neuronal repair due to the lack of neurogenic inputs from neural stem cells (Silver & 
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Miller, 2004; Costa et al., 2010). Any injury or damage in the mammalian brain draws a 
multi-cellular response; and its inability to regenerate has been associated with its 
complex functions and response from various cell-types involved (Burda & Sofroniew, 
2014). Apart from neuronal damage, there is an initial immune reaction followed by 
increased proliferation of microglia and reactive astrocytes that forms a glial scar 
(McKeon et al., 1999; Das et al., 2012; Bardehle et al., 2013). This creates a mechanical 
barrier for axonal regrowth and sustains the secretion of inhibitory factors against 
neuronal repair (Rolls et al., 2009; Burda & Sofroniew, 2014). Formation of a glial scar 
precedes NSCs response, reactive proliferation and neurogenesis, hence hindering the 
regenerative process (Christie & Turnley, 2013). All-in-all, NSCs fail to react effectively 
due to the lack of a permissive environment, and such an outcome is a prominent 
feature in neurodegenerative conditions. 
 
Neurodegeneration in the mammalian brain is caused by gradual loss of neurons and a 
lack of timely response from NSCs to replenish with new neurons, which is also 
observed in case of AD. In humans, neurogenesis is dramatically reduced in AD patients 
(Moreno-Jimenez et al., 2019; Tobin et al., 2019), suggesting that restoring 
neurogenesis could be a potential way to bring back lost neurons during AD. But the 
concept of adult neurogenesis has been questioned and is somewhat controversial 
(Arellano et al., 2018; Paredes et al., 2018; Sorrells et al., 2018). Nevertheless, recent 
studies have shown the presence of NSCs in human brains can generate new neurons 
throughout life and supports adult neurogenesis (Boldrini et al., 2018; Kempermann et 
al., 2018; Moreno-Jimenez et al., 2019; Tobin et al., 2019). This neurogenic output ability 
of NSCs in human brains has spurred an alternative approach to ameliorate 
neuropathological symptoms by inducing neurogenesis in areas where neurons are lost 
in the context of neurodegenerative conditions (Kizil & Bhattarai, 2018; Vasic et al., 
2019; Cosacak et al., 2020). However, the functional relevance of newly formed neurons 
and circuitries towards their role in cognitive improvement is not yet studied and requires 
critical investigations. 
 
Altogether, understanding the molecular basis of stem cell behavior offers a great 
platform to hypothesize the possibility of regeneration in the mammalian brain in 
neuropathological conditions. It is equally important to elucidate the molecular and 
cellular mechanism that allows permissiveness for NSCs towards neuronal 
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differentiation and functional integration (Ming & Song, 2011; Jessberger, 2016). In this 
aspect, zebrafish serves as an excellent model to delineate how it can successfully 
regenerate its brain after injury. Unlike the mammalian brain, zebrafish brain utilizes its 
endogenous NSCs to initiate regenerative neurogenesis in response to any neuronal 
insult. Special molecular mechanisms regulate the NSC plasticity towards functional 
regeneration in the zebrafish brain, and this information could be instrumental to elicit 
the neuro-regenerative aptitude in the mammalian system.  
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1.9 Aims of the thesis 
Alzheimer’s disease (AD) is a debilitating neurodegenerative disorder characterized by 
different morphological culprits, one of which is the deposition of amyloid peptides in 
form of intracellular aggregates or extracellular senile plaques that lead to gradual 
neuronal loss. Recent studies suggest that one of the reasons why humans cannot 
circumvent this disease might be due to reduced NSCs plasticity and impaired 
neurogenesis (Moreno-Jimenez et al., 2019; Tobin et al., 2019). Restoring lost neurons 
with increased neurogenesis and regeneration has been proposed as one possibility to 
counteract this disease. Towards this aspect, zebrafish serves as an excellent model to 
study neurogenesis and regeneration following neurodegenerative conditions, as it can 
efficiently regenerate its brain after various insults. It further allows us to study the 
molecular mechanisms to understand how neural stem cells can be reprogrammed 
towards neurogenesis. However, there is lack of adult zebrafish models that recapitulate 
the neurodegenerative phenotype. Thus, my thesis aims to establish a 
neurodegenerative model in adult zebrafish, associated with AD, and further utilize it to 
investigate the molecular mechanisms that induce regenerative response. In addition, 
existence of such molecular mechanisms will also be investigated in a non-regenerating 
mammalian system, which is the mouse. Overall, this information will provide us a better 
understanding of regenerative mechanisms and could also highlight the missing cues 
that could allow us to stimulate regeneration in the mammalian brain. 
 
In this project, we aim to inject synthetic amyloid peptides into the zebrafish brain using 
a cerebroventricular injection (CVMI) method (Kizil & Brand, 2011; Kizil et al., 2013; Kizil 
et al., 2015) to mimic amyloid deposition and generate amyloid-mediated 
neurodegeneration model. Additionally, we want to analyze the morphological and 
molecular response of the neural stem cells in adult the zebrafish brain following amyloid 
inclusions. We hypothesize that our approach will lead to neurodegenerative phenotype 
in adult zebrafish brain, and further elicit regenerative response. Besides, this model will 
further be used to study molecular cues that are associated with re-establishing the stem 
cell plasticity and regenerative neurogenesis. Towards that aim, whole RNA 
transcriptomics and single-cell transcriptomics analysis will be performed to analyze the 
different gene expression profiles in our model. Single-cell analyses will also allow us to 
study the heterogeneity of stem cell pool in the adult zebrafish brain, and identify 
functional subtypes of stem cells that are involved in regenerative process. We expect to 
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reveal those regeneration-associated mechanisms, and identify functional subtypes of 
NSCs population, as these findings could be useful to imply into the mammalian system 
to induce regenerative neurogenesis.  
 
Overall, it would be of great interest to understand if the mechanisms identified in 
zebrafish were the missing cues in mammals for successful regenerative response, and 
whether activating such mechanism would induce regeneration in compromised 
mammalian brain. These results would give useful insights for translational implications 
and provide scope for alternative therapeutic interventions against neurodegenerative 
diseases including AD. 
 
In short, the main aims of my thesis are: 
1. To mimic Aβ42 deposition in adult zebrafish brain and establish Aβ42-mediated 
neurodegeneration model. 
2. To characterize this model and further investigate the effects of Aβ42 deposition 
on neural stem cell plasticity and regenerative response. 
3. To study molecular mechanisms that regulates neural stem cell plasticity and 
regeneration. 
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3 Discussion and Outlook 
 
In my PhD thesis work, I established an acute model of Amyloid-mediated 
neurodegeneration in adult zebrafish that resulted in AD-like symptoms. This acute 
neurodegeneration model also induced neural regeneration by activation of endogenous 
NSCs in zebrafish and subsequent neurogenesis. This regenerative response was 
mediated by neuro-immune crosstalk involving IL-4/STAT6 signaling, where NSCs were 
directly regulated by IL-4. In addition, I further identified an IL-4 mediated indirect 
regulation of NSCs. This mechanism involved neuron-glia interaction through BDNF, 
which regulated NSCs proliferation and neurogenesis via NGFRA/NFkB signaling. 
These results demonstrate two distinct modes by which IL-4 mediates NSCs plasticity in 
neurodegenerative conditions in adult zebrafish brain. Now, in this section of my thesis, I 
will further discuss about future implications of our findings. 
 
3.1 Amyloid-mediated acute model of neurodegeneration in adult 
zebrafish 
Aggregation of amyloid protein is a hallmark of AD pathology. Using a manual 
microinjection method, we injected synthetic amyloid peptides into the zebrafish brain to 
mimic amyloid deposition in order to establish an amyloid-mediated neurodegeneration 
model in adult zebrafish (Bhattarai et al., 2016). These amyloid depositions in the brain 
elicited cytotoxic effects and resulted in acute neurodegenerative conditions, neuronal 
death, inflammation, synaptic degeneration and learning deficits, which are symptoms 
reminiscent of human AD pathology. Interestingly, we also observed enhanced 
proliferation of radial glial cells in the zebrafish brain upon amyloid deposition. These 
radial glial cells function as NSCs or neuronal progenitors, which proliferate and 
contribute to regenerative neurogenesis. Although the amyloid deposition and AD 
pathology we achieved in this model is experimental and may not cover the full chronic 
spectrum of amyloid deposition in human brain, it fills the gap for the need of a 
neurodegenerative disease model in zebrafish to study regeneration and NSCs plasticity 
by providing a reductionist model. Despite the existence of transgenic AD models in 
rodents and zebrafish, they only partially recapitulate the AD pathophysiology. Zebrafish 
lags behind the mammalian models in certain aspects, for example in terms of 
physiology and complexity. Nevertheless this acute model in zebrafish served as an 
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excellent model to study the molecular mechanisms of how NSCs can be activated to 
generate new neurons and induce regeneration after AD-like conditions. Additionally, 
this model was also successfully used for the validation of a drug that maintains 
synapses and protects synaptic integrity (Reinhardt et al., 2019). Hence, our zebrafish 
model proves to be useful in the aspect of stem-cell biology based on the strength of its 
regenerating ability and could provide useful insights into human disease, including AD. 
 
3.2 Pathology-induced mechanisms regulating NSC plasticity 
Zebrafish uses specific molecular programs to regulate neural stem cell plasticity and 
the neurogenic capacity for regenerative response. Several studies have shown that 
traumatic brain injuries in adult zebrafish lead to increased proliferation of NSCs and 
subsequent neurogenesis utilizing damage-induced regenerative molecular programs 
(Kizil et al., 2012a; Cosacak et al., 2015; Kizil, 2018). Our acute neurodegeneration 
model also increased its NSCs proliferation and induced regenerative neurogenesis in 
response to Aβ42 toxicity. We identified two distinctive molecular programs that were 
activated as a regenerative response to circumvent the neurodegenerative phenotype. 
 
One of the mechanisms identified was mediated by neuro-immune crosstalk involving IL-
4 signaling, suggesting the significant role of inflammation in regeneration. Generally, 
inflammation is regarded detrimental for NSC plasticity and regenerative ability in 
mammalian systems (Kizil et al., 2012a; Aguzzi et al., 2013). But, acute inflammatory 
response was previously shown to be essential to initiate regenerative response after 
traumatic brain injury in adult zebrafish (Kyritsis et al., 2012; Kyritsis et al., 2014). In 
accordance, our results in zebrafish showed IL-4 signaling to be necessary and sufficient 
to induce regenerative response by direct activation of NSCs following an Aβ42-
mediated neurodegenerative condition. These results revealed an important difference 
of the zebrafish brain from that of the mammalian brains by showing the distinct role of 
neuro-inflammation as an important phenomenon required for neurodegeneration-
induced regenerative plasticity of NSCs. Although, neuro-inflammatory modulators are 
known to play a pivotal role in maintaining brain homeostasis in mammals by regulating 
several processes (Kokaia et al., 2012), their role in maintaining NSC plasticity during 
disease states is ambiguous. IL-4 as an anti-inflammatory cytokine has been shown to 
modulate proliferation, survival and migration of NSCs (Butovsky et al., 2006; Guan et 
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al., 2008; Kokaia et al., 2012); however the mechanisms of these processes are still not 
clear. Interestingly, our results showed a direct effect of IL-4 in maintaining NSC 
plasticity to elicit regenerative response in adult zebrafish brain, suggesting neuro-
immune crosstalk as a crucial event underlying NSCs response. 
 
Secondly, we also identified a previously uncharacterized regulatory mechanism that 
involved a complex neuron-glia interaction mediating NSC plasticity and regenerative 
response after AD-like conditions in adult zebrafish. Here, we demonstrated that Aβ42-
induced IL-4 showed an indirect effect on a selective neuronal population modulating 
Serotonin-BDNF-NGFR axis that regulated the NSC proliferation and regenerative 
neurogenesis (Bhattarai et al., 2020). Previously, serotonin was shown to promote 
zebrafish spinal cord regeneration (Barreiro-Iglesias et al., 2015); however its specific 
receptor and associated mechanism were not studied. Our study provides a detailed 
delineation of the signaling cascade that elucidates the role of serotonin and its receptor 
in regulating NSC proliferation. Furthermore, several studies have reported a dual role of 
serotonin on modulating NSC plasticity (Alenina & Klempin, 2015), suggesting a context 
dependent mechanism that may run through intermediate factors, which in our study we 
identified as BDNF. Interestingly, a recent study in rodents shows that BDNF alone is not 
sufficient to stimulate neurogenesis (S. H. Choi et al., 2018), whereas our results in 
zebrafish show that BDNF directly regulates NSC plasticity and neurogenesis. BDNF 
binds to its receptor ngfra, expressed predominantly in NSCs, to increase NSC 
proliferation and neurogenesis in zebrafish; whereas in mouse, BDNF binds to its 
receptor TrkB, which is present in astrocytes and microglia, resulting in reactive 
astrogliosis and microgliosis. Hence, these results suggest that BDNF activity and its 
receptor signaling cascade could outline a distinct difference in NSC plasticity between 
regenerating organisms such as zebrafish and non-regenerating organisms such as 
mouse. 
 
Overall, our results show that IL-4 dependent pathology-induced microenvironment in 
adult zebrafish brain allows NSC proliferation and regenerative neurogenesis. Such 
regenerative responses are mediated through activation of distinctive signaling 
cascades, which are not active in the mammalian brain. Hence, zebrafish possess a 
natural ability to initiate NSC proliferation and regenerative neurogenesis, which could 
direct us to induce regeneration in mammalian brain after AD-like conditions. 
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3.3 Functional subtypes of NSCs that are associated with neuro-
regeneration 
NSC heterogeneity in adult zebrafish brain was recently studied based on NSCs’ spatial 
localization (Cosacak et al., 2019), which suggested only a specific sub-population of 
NSCs poses a unique plasticity feature in the event of neuronal insult. Our results also 
identified two distinct sub-populations of NSCs that had unique plasticity response based 
on the functional receptors they express. One of these NSC sub-populations expressed 
IL4R, whose plasticity response was mediated via IL4-STAT6 signaling cascade 
(Bhattarai et al., 2016), whereas another NSC subpopulation expressed NGFRA, whose 
plasticity response was mediated via BDNF-NGFRA signaling cascade (Bhattarai et al., 
2020). NSC plasticity in both of these subpopulations was mediated through distinct 
regulation of downstream genes, suggesting that NSC heterogeneity could also be 
defined based on their functional outcome. NSC heterogeneity thus serves an important 
aspect in understanding neurogenic plasticity and regenerative neurogenesis. Even in 
the disease context, particularly in Aβ42-mediated neurodegeneration model in 
zebrafish, only specific NSC subpopulation responded to amyloid toxicity (Cosacak et 
al., 2019). These results further signify the importance of understanding the diverse 
nature of NSCs in experimental mammalian models of AD. In addition, it also raises the 
question whether the mammalian brain still possesses a similar functional NSC 
subpopulation to the one present in the zebrafish brain. It would be interesting to identify 
such homologous NSC subtypes in mouse and humans. The presence of such NSC 
populations in mammalian brains would provide the potential to induce neurogenic 
response by mobilizing endogenous reservoir of NSCs and to activate regeneration-
associated mechanisms in case of neurodegenerative conditions. 
 
3.4 Inducing neuro-regeneration in mammalian brain 
In zebrafish brain, radial glial cells act as NSCs that show neurogenic competency 
throughout its life and participate in neuro-regeneration. In case of the mammalian brain, 
radial glia cells have limited neurogenic potential and rather respond by reactive 
astrogliosis in case of neurodegeneration. Radial glial cells and NSC heterogeneity has 
been studied in mouse hippocampus (Llorens-Bobadilla et al., 2015; Shin et al., 2015; 
Zeisel et al., 2015; Dulken et al., 2017), but their response in neurodegenerative 
conditions at single-cell resolution has not been extensively studied. Our results 
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demonstrated that in zebrafish, specific NSC subtypes respond to neurodegenerative 
conditions aided by specific molecular mechanisms to induce neuro-regeneration, and 
such mechanisms were found to be absent in the mammalian brain. For instance, IL4R 
is expressed in zebrafish NSCs, and results in activation of IL4/STAT6 signaling to 
induce regeneration. However, recent findings from our lab demonstrate that IL4R 
expression is not present in mouse NSCs (Mashkaryan et al., 2020), which correlates 
with inability of mouse to regenerate its lost neurons. Similarly, we also show that 
NGFRA expression is not observed in mouse NSCs (Bhattarai et al., 2020), consistent 
with previously published reports (Habib et al., 2016; Schaum et al., 2018). Additionally, 
an active NSC subtype, with a potential towards regenerative-response, has not been 
identified in mouse. A hypothetical way to elicit neurogenic response in mouse following 
any neuronal insult, such as in neurodegenerative conditions, would be to first identify 
regeneration-responsive NSC subtypes and to induce expression of IL4R or NGFR in 
those NSCs. It would be interesting to see whether activation of such regeneration-
associated molecular programs in specific NSCs of mouse brains would coax them into 
a neurogenic state. Such understanding could provide us a basis to modulate the 
endogenous NSCs in the mammalian brain, including humans, to produce new neurons 
for replacing the lost ones to counteract the neurodegenerative conditions. 
 
Overall, our findings report regeneration-associated mechanisms that are activated in 
adult zebrafish brain after Aβ42-mediated neurodegenerative conditions. These 
mechanisms activate NSCs and enhance regenerative neurogenesis in zebrafish, which 
could be an answer to induce regenerative response in mammalian brains. Our results 
thus provide a basis to investigate the possibility to elicit neurogenic response in 
mammals. Such findings could be instrumental in regenerative medicine as an 
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S1 Fig. Analyses of whole-transcriptome sequencing after IL4 treatment. (A) Sample correlation 
heat map and principle component analyses. (B, C) KEGG enriched pathways as list (B) and pie 
chart (C). (D) GO terms for biological process. (E) GO terms for molecular function. (F) 
Tryptophan metabolism in detail. Green: down-regulated enzymes, red: up-regulated enzymes 
after IL4. Related to Fig 1. See S1 Data and S2 Data for supporting information. GO, gene 




S2 Fig. Amyloid or IL4 do not cause death of 5-HT neurons. (A–C) 5-HT immunostaining in 
caudal regions of the adult zebrafish brain: Superior Raphe (A, A´), pineal stalk (B), and 
paraventricular organ (PVO) of hypothalamus (C). (D–I) 5-HT and TUNEL stainings in control (D, 
E), Aβ42-injected (F, G), and IL4-injected (H, I) zebrafish brains. (D,F,H) PVO region; (E, G, I) 
superior raphe. (F1, F2) Higher magnification images of the boxes in panel F. (G1) Higher 
magnification of the box in panel G. Scale bars equal 50 μM. Related to Fig 1. Aβ42, amyloid-
beta42; IL4, interleukin-4; PVO, paraventricular organ; TUNEL, terminal deoxynucleotidyl 
transferase dUTP nick end labeling; 5-HT, serotonin. (JPG) 
97 
 
S3 Fig. Aβ42 and IL4 antagonize the indirect effect of 5-HT on neural stem cell plasticity. (A–D) 
IHC for S100β and PCNA on control (A), 5-HT-injected (B), 5-HT + Aβ42-injected (C), and 5-HT + 
IL4-injected (D) zebrafish brains. (E) Quantification of proliferating glial cells in all conditions. (F) 
Read numbers of all serotonin receptors in her4.1+ cellspositive cells (PCs) in the adult zebrafish 
telencephalon as a graphical representation that is derived from deep sequencing results. Glial 
markers gfap and s100 are given as positive controls. (G) ISH panels of htr1aa, htr1ab, and 
htr1d. Note that progenitor cells/glia do not express serotonin receptors. (H) Electrophysiology 
in 1-month-old her4.1:GFP zebrafish telencephalon. GFP+ cellspositive cells (NSCs) were patched 
with electrodes, and the effect of 5-HT on membrane polarization was measured. NSCs are not 
responsive to 5-HT but periventricular neurons that are GFP-negative are. n > 9 for 
electrophysiology experiments. Scale bars equal 100 μM. Related to Fig 2. See S7 Data for 
supporting information. Aβ42, amyloid-beta42; IHC, immunohistochemistry; IL4, interleukin-4; 







S4 Fig. Single-cell sequencing analyses of adult zebrafish telencephalon after serotonin 
treatment. (A) Schematic workflow for single-cell sequencing. (B) Quality control indicators of 
single-cell sequencing data: VLN plots for principal component analyses, variable gene plots, 
distribution plots for number of genes (nGene), number of reads (nUMI), % ofmitochondrial 
genes (%mito), and gene plots for %mito, nGene, and %GFP (from sorted  her4.1-GFP cells). (C) 
Primary tSNE feature plots indicating major cell clusters with canonical markers: sypb and gap43 
for neurons, olig2 and aplnrb for oligodendrocytes, gfap and her4 for glia, pfn1 and lcp1 for 
immune cells. (D) Primary heat map for top 40 marker genes of neurons, glia, oligodendrocytes, 
and immune cells. (E) Classification of major cell clusters for their identities based on markers. 
(F) Feature plots for htr1 and il4r expression. Note that htr1-positive cells are neurons whereas 
il4r-positive cells are glia. (G) Strategy for isolating htr1-expressing cells from tSNE plot and 
subsequent differential expression analyses. (H) VLN plots for bdnf, ngfra, and ntrk2 in major 
cell types and expression level ratios as pie charts. Related to Fig 3. See S3 Data for supporting 
information. GFP, green fluorescent protein; tSNE, t-Distributed stochastic neighbor embedding; 





S5 Fig. Comparison of de novo clustering with Seurat and machine learning paradigm. Cells are 
color-coded in samples (A), cell clusters predicted by RandomForest (B), and cell clusters 
identified by Seurat (C) after using all 4 experimental groups together. To use the same neuronal 
and progenitor clusters we identified before ([34]), we used RandomForest and machine 
learning (B) in our analyses. By using Seurat (C), cell clusters can also be inferred de novo. The 
cell clusters and their top marker genes are identical, whereas some cell clusters (e.g., neurons) 
can be further subdivided depending on the algorithm used. The color codes used in the middle 
panel are the same colors used in [34]. The colors of PCs are also used in Seurat analyses (A). A 
few cells from Aβ42 and 5-HT groups do not exist in other groups (control and IL4). These cells 
express olfactory bulb markers and are contaminations of cells in sample preparation. They 
cluster separately from all groups we analyzed and are not affecting the biological outcomes of 
the analyses. Related to Fig 3. See S3 Data for supporting information. Aβ42, amyloid-beta42; 




S6 Fig. Serotonin suppresses and BDNF enhances NFkB signaling in NSCs in zebrafish. (A) In 
silico interaction map for NTRK2 in Aβ42 versus control, IL4 versus control, and 5-HT versus 
control comparisons. Black arrows: interactions unchanged with treatment, cyan arrows: 
interaction lost with treatment, magenta arrows: interaction gained/emerged with the 
treatment. (B) ISH for ntrk2 in zebrafish brain. (B´) Close-up image. Note the expression in pvz 
but not in vz that contains the NSCs. (C) IHC for Ntrk2 protein in zebrafish brain, supporting the 
ISH results and presence of Ntrk2 in pvz. (D, E) IHC for pAkt in control (D) and BDNF-injected (E) 
brains. BDNF activates pAkt in pvz but not in vz. (F) ISH for ngfra in adult zebrafish telecephalon. 
(G) IHC for S100β, NfkB-driven GFP, and PCNA in control, Amyloidinjected, IL4-injected, 5-HT-
injected, and BDNF-injected brains. Smaller panels under larger images show individual 
fluorescent channels. (H) Quantification of the relative number of proliferating NSCs that have 
active NFkB signaling. Scale bars equal 100 μM. Data are represented as mean ± SEM. Related to 
Fig 4. See S7 Data for supporting information. BDNF, brain-derived neurotrophic factor; GFP, 
green fluorescent protein; IHC, immunohistochemistry; IL4, interleukin-4; ISH, in situ 
hybridization; NFkB, nuclear factor ’kappa-light-chainenhancer’ of activated B-cells; NSC, neural 
stem cell; NTRK2, neurotrophic tyrosine kinase receptor, type 2; pAkt, phosphorylated protein 
kinase B; PCNA, proliferating cell nuclear antigen; pvz, periventricular zone; S100β, S100 




S7 Fig. BDNF does not induce NSC plasticity in mouse model of AD. (A, B) IHC for GFAP and 
SOX2 in WT (A) and APP/PS1dE9 mouse brains (B) at 12 months of age. (A1, A2) Single 
fluorescent channels of panel A. (B1, B2) Single fluorescent channels of panel B. (C–D´) IHC for 
GFAP and BDNF in WT mouse: (C) cortex, (D) DG. Primed images are higher magnification 
without DAPI. (E–F´) IHC for GFAP and BDNF in APP/PS1dE9 mouse: (E) cortex, (F) DG. Primed 
images are higher magnification without DAPI. (G–H´) IHC for GFAP and NTRK2 in WT mouse: (G) 
cortex, (H) DG. Primed images are higher magnification without DAPI. (I–J´) IHC for GFAP and 
NTRK2 in APP/PS1dE9 mouse: (I) cortex, (J) DG. Primed images are higher magnification without 
DAPI. (K–L´) IHC for NeuN and p75/NTR in WT mouse: (K) cortex, (L) DG. Primed images are 
higher magnification without DAPI. (M–N´) IHC for NeuN and p75/NTR in APP/PS1dE9 mouse: 
(M) cortex, (N) DG. Primed images are higher magnification without DAPI. (O–R2) IHC for Ki67 
and GFAP in WT mouse PBS injected hemisphere (O), wt mouse BDNF-injected hemisphere (P), 
APP/PS1dE9 mouse PBS injected hemisphere (Q), APP/PS1dE9 mouse BDNF-injected 
hemisphere (R). (S–V2) IHC for Ki67 and Iba1 in WT mouse PBS-injected hemisphere (S), WT 
mouse BDNF-injected hemisphere (T), APP/PS1dE9 mouse PBS-injected hemisphere (U), 
APP/PS1dE9 mouse BDNF-injected hemisphere (V). (W) High-magnification image of Ki67 and 
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GFAP staining on DG of BDNF-injected hemisphere of APP/PS1dE9 mouse. GFAP cells do not 
proliferate after BDNF injection. (X) High-magnification image of Ki67 and Iba1 staining on DG of 
BDNF-injected hemisphere of APP/PS1dE9 mouse. Most Ki67-positive cells overlap with Iba1 
staining after BDNF injection. n = 2 animals used for analyses. Scale bars equal 100 μM Related 
to Fig 4. AD, Alzheimer disease; BDNF, brain-derived neurotrophic factor; DG, dentate gyrus; 
GFAP, glial fibrillary acidic protein; Iba1, ionized calcium binding adaptor molecule 1; IHC, 
immunohistochemistry; Ki67, antigen identified by monoclonal antibody Ki-67; NeuN, Fox-3, 
Rbfox3, or Hexaribonucleotide binding protein 3; NSC, neural stem cell; NTRK2, neurotrophic 
tyrosine kinase, receptor, type 2; SOX2, (sex determining region Y)-box transcription factor 2; 





S8 Fig. BDNF and NTRK2 expression in mouse brain. (A, A´) IHC for amyloid plaques (4G8) in 
wild-type mouse hippocampus. (B–F) IHC for GFAP, SOX2, and BDNF in wild-type mouse brains. 
(G, G´) IHC for amyloid plaques (4G8) in APP/PS1dE9 mouse hippocampus. (H–L) IHC for GFAP, 
SOX2, and BDNF in APP/PS1dE9 mouse brains. Mice were at the age of 12 months. (M) IHC for 
GFAP and NTRK2 in wild-type mouse DG. (M´) Single fluorescent channel for NTRK2. (N) High 
magnification of merged image. (N´) Single fluorescent channel for NTRK2 in panel N. (O) IHC for 
Iba1 and NTRK2. (O´) Single fluorescent channel for NTRK2 in panel O. (O˝) single fluorescent 
channel for Iba1 in panel O. (P) IHC for NTRK2 and NeuN. Single channel in red is NTRK2. Scale 
bars equal 100 μM. Related to Figs 4 and 5. BDNF, brain-derived neurotrophic factor; DG, 
dentate gyrus; GFAP, glial fibrillary acidic protein; Iba1, ionized calcium binding adaptor 
molecule 1; IHC, immunohistochemistry; NeuN, Fox-3, Rbfox3, or Hexaribonucleotide binding 
protein 3; IHC, immunohistochemistry; NTRK2, neurotrophic tyrosine kinase, receptor, type 2; 





S9 Fig. p75/NTR expression in mouse brain. (A–C) IHC for p75/NTR (NGFR) in wild-type cortex 
(A), DG (B), and SVZ (C). (D–K) IHC for p75/NTR and NeuN in cortex (D) and DG (H). (E–G) High-
magnification image from panel D. (I–K) High-magnification image from panel H. (L–S) IHC for 
p75/NTR and NeuN in cortex (L) and DG (P) of APP/PS1dE9 mouse. (M–O) High-magnification 
image from panel L. (Q–S) High-magnification image from panelP. Scale bars equal 100 μM. 
Related to Figs 4 and 5. DG, dentate gyrus; IHC, immunohistochemistry; NeuN, Fox-3, Rbfox3, or 
Hexaribonucleotide binding protein 3; NGFR, nerve growth factor receptor; p75/NTR, 




S10 Fig. BDNF increases the proliferation of microglia but does not affect the astrocytes in the 
mouse brain. (A, B) IHC for Ki67 and GFAP in wild-type (A) and APP/PS1dE9 (B) mouse brains at 
12 months of age after injection of PBS (left hemisphere) and BDNF (right hemisphere). (C) 
Close-up image of the DG of a BDNF-injected side of the APP/PS1dE9 mouse brain. (D, E) IHC for 
Ki67 and Iba1 in wild-type (D) and APP/PS1dE9 (E) mouse brains at 12 months of age after 
injection of PBS (left hemisphere) and BDNF (right hemisphere). (F) Close-up image of the DG of 
a BDNF-injected side of the APP/PS1dE9 mouse brain. Scale bars equal 100 μM. Related to Figs 4 
and 5. BDNF, brain-derived neurotrophic factor; DG, dentate gyrus; Ki67, antigen identified by 
monoclonal antibody Ki-67; GFAP, glial fibrillary acidic protein; Iba1, ionized calcium binding 
adaptor molecule 1; IHC, immunohistochemistry; NeuN, Fox-3, Rbfox3, or Hexaribonucleotide 
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